Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Add an action for DRTS.US, or sign in to see your action list.
| Name | Title | Year Born |
|---|---|---|
| Mr. Uzi Sofer | CEO & Chairman | 1970 |
| Mr. Raphi Levy | Chief Financial Officer | 1985 |
| Mr. Amnon Gat | Chief Operations Officer | 1975 |
| Mr. Ronen Segal | Chief Technology Officer | 1973 |
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board | 1979 |
| Prof. Yona Keisari | Chief Scientific Officer | 1947 |
| Ms. Rebecca Becker | Vice President of legal | NA |
| Ms. Yael Zeiger | Corporate Controller | 1983 |
Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.